1. Home
  2. MRT vs ALXO Comparison

MRT vs ALXO Comparison

Compare MRT & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marti Technologies Inc.

MRT

Marti Technologies Inc.

HOLD

Current Price

$1.95

Market Cap

176.2M

ML Signal

HOLD

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

N/A

Current Price

$2.01

Market Cap

205.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MRT
ALXO
Founded
2018
2015
Country
Turkey
United States
Employees
N/A
N/A
Industry
Rental/Leasing Companies
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
176.2M
205.9M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
MRT
ALXO
Price
$1.95
$2.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$3.58
$3.50
AVG Volume (30 Days)
46.0K
1.0M
Earning Date
08-08-2018
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
26.36
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$72.36
N/A
Revenue Next Year
$95.75
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.12
$1.02
52 Week High
$2.75
$2.66

Technical Indicators

Market Signals
Indicator
MRT
ALXO
Relative Strength Index (RSI) 64.77 50.59
Support Level $1.99 $1.90
Resistance Level $2.29 $2.17
Average True Range (ATR) 0.13 0.10
MACD 0.01 0.00
Stochastic Oscillator 92.73 47.92

Price Performance

Historical Comparison
MRT
ALXO

About MRT Marti Technologies Inc.

Marti Technologies Inc is Turkiye's urban mobility platform, helping to solve the country's transportation needs through tech-enabled services powered by a single mobility super app. The Group aims to offer tech-enabled urban transportation services to consumers across Turkiye through three service offerings: ride-hailing, delivery, and two-wheeled electric vehicle services. The Group's ride-hailing service matches consumers with car, motorcycle, and taxi drivers. The Group's delivery service provides same-hour package delivery by leveraging the Group's existing network of car and motorcycle drivers and consumer base.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: